Author pages are created from data sourced from our academic publisher partnerships and public sources.
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.
- T. Naftali, Lihi Bar-Lev Schleider, I. Dotan, Ephraim Philip Lansky, F. Sklerovsky Benjaminov, F. Konikoff
- Clinical gastroenterology and hepatology : the…
- 1 October 2013
BACKGROUND & AIMS The marijuana plant Cannabis sativa has been reported to produce beneficial effects for patients with inflammatory bowel diseases, but this has not been investigated in controlled… Expand
Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience
- Y. Balash, Lihi Bar-Lev Schleider, +7 authors T. Gurevich
- Clinical neuropharmacology
- 1 November 2017
Background The use of medical cannabis (MC) is controversial. Support for its benefits is based on small clinical series. Objective The aim of this study was to report the results of a standardized… Expand
Safety and Efficacy of Medical Cannabis in Fibromyalgia
- I. Sagy, Lihi Bar-Lev Schleider, M. Abu-Shakra, V. Novack
- Journal of clinical medicine
- 1 June 2019
Background: Chronic pain may be treated by medical cannabis. Yet, there is scarce evidence to support the role of medical cannabis in the treatment of fibromyalgia. The aim of the study was to… Expand
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
- Lihi Bar-Lev Schleider, R. Mechoulam, N. Saban, G. Meiri, V. Novack
- Scientific Reports
- 17 January 2019
There has been a dramatic increase in the number of children diagnosed with autism spectrum disorders (ASD) worldwide. Recently anecdotal evidence of possible therapeutic effects of cannabis products… Expand
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer.
- Lihi Bar-Lev Schleider, R. Mechoulam, +5 authors V. Novack
- European journal of internal medicine
- 1 March 2018
BACKGROUND Cancer is a major public health problem as the leading cause of death. Palliative treatment aimed to alleviate pain and nausea in patients with advanced disease is a cornerstone of… Expand
Medical cannabis: aligning use to evidence‐based medicine approach
- Lihi Bar-Lev Schleider, Ran Abuhasira, V. Novack
- British journal of clinical pharmacology
- 1 November 2018
During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has… Expand
Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects.
- T. Naftali, Lihi Bar-Lev Schleider, F. Sklerovsky Benjaminov, I. Lish, F. Konikoff, Y. Ringel
- European journal of gastroenterology & hepatology
- 1 November 2019
OBJECTIVE Use of medical cannabis for improving symptoms of inflammatory bowel disease is increasing. However, reports on long-term outcomes are lacking. This prospective, observational study… Expand
Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial.
- T. Naftali, Lihi Bar-Lev Schleider, Fabiana Scklerovsky Benjaminov, F. Konikoff, Shelly Tartakover Matalon, Y. Ringel
- PloS one
BACKGROUND Cannabis is often used by patients with ulcerative colitis, but controlled studies are few. We aimed to assess the effect of cannabis in improving clinical and inflammatory outcomes in… Expand